TCBPY — TC Biopharm (Holdings) Share News
0.000.00%
Last trade - 00:00Brief: TC BioPharm Announces Complete Response In Minimal Residual Disease Patient
Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Brief: TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML
Brief: TCBP Trading Continues Unabated On Nasdaq Stock Exchange
Brief: Tcbp Announces General Meeting Of Shareholders To Approve One-Time Shareholder Dividend
Brief: TC Biopharm (Holdings)- Entered At Market Offering Agreement, Relating To Sale Of American Depositary Shares Of Up To $14 Mln, From Time To Time
Brief: TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial
Brief: TC Biopharm (Holdings) PLC Files For Mixed Shelf Of Up To $100 Million
Brief: Tcbp Enters Research Planning Collaboration With Dr. Carlos Maluquer De Motes For Mpox Therapeutic
Brief: TCBP Announces First Patient Completed Full Fose Regimen In ACHIEVE Clinical Trial
Brief: TC BioPharm Intends To Launch Preclinical Studies For Treatment Of Monkey Pox
Brief: TC Biopharm Intends To Launch Preclinical Studies For Treatment Of Monkey Pox
Brief: TCBP Announces Dosing Of 5 New Patients In ACHIEVE
Brief: TCBP Announces Execution Of Non-Binding Letter Of Intent For Acquisition Of NK Platform Technologies
Brief: TCBP Increasing Treatment Capacity With Expanded Manufacturing Process
U.S. STOCKS ON THE MOVE-Viatris, National Fuel Gas, Moderna
U.S. STOCKS ON THE MOVE-Hyatt, Fortrea, China ADRs
Brief: TCBP Announces MHRA Acceptance Of Amendment For ACHIEVE UK Trial
Brief: TC Biopharm Announces Additional Cost Reduction Steps